1. Home
  2. APLT vs DOGZ Comparison

APLT vs DOGZ Comparison

Compare APLT & DOGZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • APLT
  • DOGZ
  • Stock Information
  • Founded
  • APLT 2016
  • DOGZ 2003
  • Country
  • APLT United States
  • DOGZ China
  • Employees
  • APLT N/A
  • DOGZ N/A
  • Industry
  • APLT Biotechnology: Pharmaceutical Preparations
  • DOGZ Miscellaneous manufacturing industries
  • Sector
  • APLT Health Care
  • DOGZ Consumer Discretionary
  • Exchange
  • APLT Nasdaq
  • DOGZ Nasdaq
  • Market Cap
  • APLT 178.6M
  • DOGZ 165.1M
  • IPO Year
  • APLT 2019
  • DOGZ 2017
  • Fundamental
  • Price
  • APLT $1.28
  • DOGZ $11.57
  • Analyst Decision
  • APLT Buy
  • DOGZ
  • Analyst Count
  • APLT 5
  • DOGZ 0
  • Target Price
  • APLT $4.13
  • DOGZ N/A
  • AVG Volume (30 Days)
  • APLT 5.5M
  • DOGZ 263.3K
  • Earning Date
  • APLT 11-10-2025
  • DOGZ 10-17-2025
  • Dividend Yield
  • APLT N/A
  • DOGZ N/A
  • EPS Growth
  • APLT N/A
  • DOGZ N/A
  • EPS
  • APLT N/A
  • DOGZ N/A
  • Revenue
  • APLT $121,000.00
  • DOGZ $20,707,707.00
  • Revenue This Year
  • APLT N/A
  • DOGZ N/A
  • Revenue Next Year
  • APLT $5,935.35
  • DOGZ N/A
  • P/E Ratio
  • APLT N/A
  • DOGZ N/A
  • Revenue Growth
  • APLT N/A
  • DOGZ 39.47
  • 52 Week Low
  • APLT $0.30
  • DOGZ $6.81
  • 52 Week High
  • APLT $10.62
  • DOGZ $58.00
  • Technical
  • Relative Strength Index (RSI)
  • APLT 60.36
  • DOGZ 33.93
  • Support Level
  • APLT $1.16
  • DOGZ $11.11
  • Resistance Level
  • APLT $1.50
  • DOGZ $15.61
  • Average True Range (ATR)
  • APLT 0.14
  • DOGZ 0.95
  • MACD
  • APLT -0.02
  • DOGZ -0.37
  • Stochastic Oscillator
  • APLT 61.64
  • DOGZ 10.22

About APLT Applied Therapeutics Inc.

Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.

About DOGZ Dogness (International) Corporation

Dogness (International) Corp designs, manufactures pet products, including leashes and smart products, and lanyards. The company designs, processes, and manufactures fashionable and high-quality leashes, collars, and harnesses to complement cats' and dogs' appearances, as well as intelligent pet products. The company also provides dyeing services to external customers, as well as pet grooming services. The dyeing service is to utilize the existing production capacity and the pet grooming service is immaterial. Geographically, it generates maximum revenue from Mainland China and also has a presence in the United States, Europe, Australia, Canada, Central, and South America, Japan, and other Asian countries and regions.

Share on Social Networks: